Related Experiment Videos
An exact analysis of the multistage model explaining dose-response concavity
1Cox Associates, Denver, Colorado 80218, USA.
Summary
The traditional multistage (MS) model of carcinogenesis relies on rare-tumor approximations. An exact two-stage model better fits chemical bioassay data, especially for non-negligible tumor rates.
Area of Science:
- Toxicology and Carcinogenesis
- Mathematical Modeling
- Biostatistics
Background:
- The multistage (MS) model of carcinogenesis predicts specific dose-response function properties.
- These properties, including convex cumulative hazards, are often not observed empirically for some chemicals.
- The discrepancy arises from approximations in the traditional MS model analysis.
Purpose of the Study:
- To re-evaluate the mechanistic assumptions of the MS model.
- To present an exact probabilistic analysis of a two-stage carcinogenesis model.
- To demonstrate the utility of the exact model in fitting empirical bioassay data.
Main Methods:
- Developed an exact probabilistic analysis for a two-stage MS model.
- Applied the model to scenarios with simultaneous or sequential carcinogen action.
- Utilized least-squares fitting to analyze real bioassay datasets.
Main Results:
- The exact two-stage model explains concave cumulative hazard functions not predicted by the traditional MS model.
- The model successfully fits bioassay data for chemicals like 1,3-butadiene.
- Properties inconsistent with empirical data are resolved using the exact model.
Conclusions:
- The simplifying rare-tumor approximations in the traditional MS model lead to inaccurate predictions.
- An exact two-stage model provides a more accurate representation of carcinogenesis.
- The exact model is recommended for bioassay experiments with tumor rates exceeding 10%.